Trademark: 86567132
Word
COVANCE
Status
Registered
Status Code
705
Status Date
Thursday, November 4, 2021
Serial Number
86567132
Registration Number
4897521
Registration Date
Tuesday, February 9, 2016
Mark Type
3000
Filing Date
Tuesday, March 17, 2015
Published for Opposition
Tuesday, November 24, 2015

Trademark Owner History

Classifications
9 Downloadable electronic publications, namely, books, pamphlets, articles, technical manuals, instructional and teaching materials, and reports in the fields of research and development of pharmaceutical, medical devices, biotechnology, and biochemicals
16 Printed matter, namely, books, pamphlets, articles, technical manuals, instructional and teaching materials, and reports in the fields of research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals
36 Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; financial administration of patient reimbursement programs
35 Business consultancy services; business management consultancy and advisory services; consultancy and advisory services in the field of business strategy; marketing services; regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; economic forecasting and analysis; market research; business consulting services in the field of commercialization of pharmaceuticals, medical devices, biotechnology, and biochemicals; business management services, namely, forecasting drug supplies for clinical trials; business management services, namely, recruiting patients and volunteers for clinical trials; business administration of patient reimbursement programs; project management services for others for business purposes in the field of research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; database management; business information services; business data analysis; business advice and commercial information
45 Regulatory compliance consulting in the fields of pharmaceuticals and medical devices; regulatory compliance consulting in the field of obtaining government authorization to market pharmaceuticals and medical devices; regulatory compliance consulting in the field of food safety and nutritional labeling; providing information and advisory services about regulatory compliance in the fields of pharmaceuticals, medical devices, food safety, and nutritional labeling
44 Medical services in the fields of pathology, pharmacology, and immunology; medical and psychological counseling; providing medical information and advice in the fields of pathology, pharmacology, and immunology; collection, organization, analysis, and reporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices
31 [ Live animals; live laboratory animals ]
42 Scientific research and development; pharmaceutical drug development and testing services; research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of clinical and non-clinical trials and studies on pharmaceuticals and medical devices; collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory services, namely, formulating and bioprocessing pharmaceuticals; rental of laboratory apparatus and instruments; operating and maintaining a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; custom design and development of chemical reagents and biochemical assays; medical laboratory services in the field of pathology; testing of laboratory animals for scientific research purposes; computer hardware and software design; development, updating and maintenance of software and databases; design and development of software for use in conducting animal and biological research in non-clinical pharmaceutical and medical device and development studies; providing online computer databases in the fields of research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; data mining; providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices; food safety testing and consultation related thereto; scientific research and analysis in the fields of food safety, food packaging, and nutritional chemistry; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug development, namely, selecting animal and biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug development, namely, selecting biomarkers for use in testing drugs; lead candidate drug optimization services, namely, scientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistry, pharmaceuticals and clinical trials; providing online non-downloadable software for tracking, monitoring, analyzing, generating and reporting information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices
The mark consists of the literal element "COVANCE" in blue, under a curved design in red.
The color(s) blue and red is/are claimed as a feature of the mark.

Trademark Events
Sep 7, 2022
Automatic Update Of Assignment Of Ownership
Nov 4, 2021
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Nov 4, 2021
Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Nov 4, 2021
Case Assigned To Post Registration Paralegal
Jul 30, 2021
Teas Section 8 & 15 Received
Feb 9, 2021
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Sep 20, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 20, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 9, 2016
Registered-Principal Register
Nov 24, 2015
Official Gazette Publication Confirmation E-Mailed
Nov 24, 2015
Published For Opposition
Nov 4, 2015
Notification Of Notice Of Publication E-Mailed
Oct 16, 2015
Law Office Publication Review Completed
Oct 7, 2015
Approved For Pub - Principal Register
Oct 7, 2015
Assigned To Examiner
Sep 15, 2015
Teas/Email Correspondence Entered
Sep 15, 2015
Correspondence Received In Law Office
Sep 15, 2015
Teas Response To Office Action Received
Jun 23, 2015
Notification Of Non-Final Action E-Mailed
Jun 23, 2015
Non-Final Action E-Mailed
Jun 23, 2015
Non-Final Action Written
Jun 19, 2015
Assigned To Examiner
Apr 6, 2015
Preliminary/Voluntary Amendment - Entered
Apr 6, 2015
Assigned To Lie
Mar 30, 2015
Teas Voluntary Amendment Received
Mar 27, 2015
Notice Of Design Search Code E-Mailed
Mar 26, 2015
New Application Office Supplied Data Entered In Tram
Mar 20, 2015
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24